WHO Drug Information Vol. 24, No. 4, 2010
WHO Drug Information Vol. 24, No. 4, 2010
WHO Drug Information Vol. 24, No. 4, 2010
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Proposed INN: List 104 <strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong>, <strong>Vol</strong>. <strong>24</strong>, <strong>No</strong>. 4, <strong>2010</strong>Proposed International <strong>No</strong>n Proprietary Names (Prop. INN): List 101Denominations communes internationales proposées (DCI Prop.): Liste 101Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 101(<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong>, <strong>Vol</strong>. 23, <strong>No</strong>. 2, 2009)p. 146 fonturacetamumfonturacetamfonturacétamfonturacetamreplace the chemical name by the followingremplacer le nom chimique par le suivantsustitúyase el nombre químico por el siguienterac-2-(2-oxo-4-phenylpyrolidin-1-yl)acetamiderac-2-(2-oxo-4-phénylpyrolidin-1-yl)acétamiderac-2-(4-fenil-2-oxopirolidin-1-il)acetamidap. 165 sifalimumabumsifalimumabsifalimumabsifalimumabreplace the description by the followingremplacer la description par la suivantesustitúyase la descripción por la siguienteimmunoglobulin G1-kappa, anti-[Homo sapiens interferon alpha (IFN-alpha)],Homo sapiens monoclonal antibody;gamma1 heavy chain (1-446) [Homo sapiens VH (IGHV1-18*01 (95.90%) -(IGHD)-IGHJ4*01) [8.8.9] (1-116) –IGHG1*03 CH1 R120>K (213) (117-446)],(219-213')-disulfide with kappa light chain (1'-215') [Homo sapiens V-KAPPA(IGKV3-20*01 (99.00%) –IGKJ1*01) [7.3.9] (1'-108') -IGKC*01 (109'-215')];(225-225'':228-228'')-bisdisulfide dimerimmunoglobuline G1-kappa, anti-[Homo sapiens interféron alpha (IFN-alpha)],Homo sapiens anticorps monoclonal;chaîne lourde gamma1 (1-446) [Homo sapiens VH (IGHV1-18*01 (95.90%) -(IGHD)-IGHJ4*01) [8.8.9] (1-116) –IGHG1*03 CH1 R120>K (213) (117-446)],(219-215')-disulfure avec la chaîne légère kappa (1'-215') [Homo sapiens V-KAPPA (IGKV3-20*01 (99.00%) –IGKJ1*01) [7.3.9] (1'-108') -IGKC*01 (109'-215')]; dimère (225-225'':228-228'')-bisdisulfureinmunoglobulina G1-kappa, anti-[interferón alfa (IFN-alfa) de Homosapiens], anticuerpo monoclonal de Homo sapiens;cadena pesada gamma1 (1-446) [Homo sapiens VH (IGHV1-18*01(95.90%) -(IGHD)-IGHJ4*01) [8.8.9] (1-116) –IGHG1*03 CH1R120>K (213) (117-446)], (219-215')-disulfuro con la cadena ligera kappa(1'-215') [Homo sapiens V-KAPPA (IGKV3-20*01 (99.00%) –IGKJ1*01) [7.3.9] (1'-108') -IGKC*01 (109'-215')]; dímero (225-225'':228-228'')-bisdisulfurop. 169 delete/supprimer/suprimáse insert/insérer/insertesetanexabanumtanexabantanexabantanexabándarexabanumdarexabandarexabandarexabán402
Change language